2021 WHO:COVID-19临床管理生活指南

2021-11-23 世界卫生组织 WHO官网

WHO COVID-19 临床管理:生活指南包含WHO组织针对 COVID-19 患者临床管理的最新建议。为 COVID-19 患者在整个疾病期间的最佳护理提供全面和整体的指导非常重要。

中文标题:

2021 WHO:COVID-19临床管理生活指南

发布机构:

世界卫生组织

发布日期:

2021-11-23

简要介绍:

WHO COVID-19 临床管理:生活指南包含WHO组织针对 COVID-19 患者临床管理的最新建议。为 COVID-19 患者在整个疾病期间的最佳护理提供全面和整体的指导非常重要。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 WHO:COVID-19临床管理生活指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1eded1c00228096a, title=2021 WHO:COVID-19临床管理生活指南, enTitle=, guiderFrom=WHO官网, authorId=0, author=, summary=WHO COVID-19 临床管理:生活指南包含WHO组织针对 COVID-19 患者临床管理的最新建议。为 COVID-19 患者在整个疾病期间的最佳护理提供全面和整体的指导非常重要。, cover=https://img.medsci.cn/2021121/1638350972730_1608702.jpg, journalId=0, articlesId=null, associationId=138, associationName=世界卫生组织, associationIntro=null, copyright=0, guiderPublishedTime=Tue Nov 23 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #1a1a1a;">WHO&nbsp;</span><em style="color: #1a1a1a;">COVID-19 临床管理:生活指南</em><span style="color: #1a1a1a;">包含WHO组织针对 COVID-19 患者临床管理的最新建议。为 COVID-19 患者在整个疾病期间的最佳护理提供全面和整体的指导非常重要。</span></p>, tagList=[TagDto(tagId=99632, tagName=Covid-19)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=99632, guiderKeyword=Covid-19, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=138371, appHits=46, showAppHits=0, pcHits=702, showPcHits=138325, likes=1, shares=6, comments=5, approvalStatus=1, publishedTime=Wed Dec 01 17:36:24 CST 2021, publishedTimeString=2021-11-23, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Wed Dec 01 17:35:35 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 20:22:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 WHO:COVID-19临床管理生活指南.pdf)])
2021 WHO:COVID-19临床管理生活指南.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1185614, encodeId=b370118561458, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63be3008387, createdName=794543371, createdTime=Tue Jan 18 13:55:19 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077917, encodeId=2af510e7917bf, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/006878ac339c4343b5509001fa5cc8e8/cf12a0d797b042619ed7e552d07f03a1.jpg, createdBy=037f5610137, createdName=ms8000001286515063, createdTime=Tue Dec 07 23:54:51 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077916, encodeId=3fc510e791687, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/006878ac339c4343b5509001fa5cc8e8/cf12a0d797b042619ed7e552d07f03a1.jpg, createdBy=037f5610137, createdName=ms8000001286515063, createdTime=Tue Dec 07 23:54:18 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077013, encodeId=a12b10e701303, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:20:24 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2022-01-18 794543371

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1185614, encodeId=b370118561458, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63be3008387, createdName=794543371, createdTime=Tue Jan 18 13:55:19 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077917, encodeId=2af510e7917bf, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/006878ac339c4343b5509001fa5cc8e8/cf12a0d797b042619ed7e552d07f03a1.jpg, createdBy=037f5610137, createdName=ms8000001286515063, createdTime=Tue Dec 07 23:54:51 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077916, encodeId=3fc510e791687, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/006878ac339c4343b5509001fa5cc8e8/cf12a0d797b042619ed7e552d07f03a1.jpg, createdBy=037f5610137, createdName=ms8000001286515063, createdTime=Tue Dec 07 23:54:18 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077013, encodeId=a12b10e701303, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:20:24 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2021-12-07 ms8000001286515063

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1185614, encodeId=b370118561458, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63be3008387, createdName=794543371, createdTime=Tue Jan 18 13:55:19 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077917, encodeId=2af510e7917bf, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/006878ac339c4343b5509001fa5cc8e8/cf12a0d797b042619ed7e552d07f03a1.jpg, createdBy=037f5610137, createdName=ms8000001286515063, createdTime=Tue Dec 07 23:54:51 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077916, encodeId=3fc510e791687, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/006878ac339c4343b5509001fa5cc8e8/cf12a0d797b042619ed7e552d07f03a1.jpg, createdBy=037f5610137, createdName=ms8000001286515063, createdTime=Tue Dec 07 23:54:18 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077013, encodeId=a12b10e701303, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:20:24 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2021-12-07 ms8000001286515063

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1185614, encodeId=b370118561458, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63be3008387, createdName=794543371, createdTime=Tue Jan 18 13:55:19 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077917, encodeId=2af510e7917bf, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/006878ac339c4343b5509001fa5cc8e8/cf12a0d797b042619ed7e552d07f03a1.jpg, createdBy=037f5610137, createdName=ms8000001286515063, createdTime=Tue Dec 07 23:54:51 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077916, encodeId=3fc510e791687, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/006878ac339c4343b5509001fa5cc8e8/cf12a0d797b042619ed7e552d07f03a1.jpg, createdBy=037f5610137, createdName=ms8000001286515063, createdTime=Tue Dec 07 23:54:18 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077013, encodeId=a12b10e701303, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:20:24 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2021-12-05 微探

    学习学习

    0

拓展阅读

COVID-19感染患者的气管切开术共识:西班牙

西班牙重症监护医学与冠心病小组学会(SEMICYUC,Spanish Society of Intensive Care Medicine and Coronary Units) · 2020-06-01

肺癌和COVID-19大流行:巴西胸部肿瘤小组的建议

巴西胸部肿瘤组织(Brazilian Thoracic Oncology Group) · 2020-09-01